ENO1 is a glycolytic enzyme that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate in the glycolytic pathway [17] and is frequently overexpressed in tumor cells in association with cancer progression [18]. Here, HK1 is linked to neoplasm.